Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
European Urology Oncology
|
August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
Joe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
BMC Medical Informatics and Decision Making
|
August 27, 2013
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
Kerri M Clough-Gorr, Lea Noti, Peter Brauchli, et al.
Prostate Cancer and Prostatic Diseases
|
April 8, 2024
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials
Mohamed Shelan, Vérane Achard, Felix Appiagyei, et al.
Lancet (London, England)
|
September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Eva Compérat, Mahul B Amin, Richard Cathomas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 27, 2013
Multidisciplinary care in patients with prostate cancer: room for improvement
Räto T Strebel, Tullio Sulser, Hans-Peter Schmid, et al.
BMC Urology
|
September 11, 2019
Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience
Christoph Oehler, Michel Zimmermann, Lukas Adam, et al.
Clinical Genitourinary Cancer
|
January 29, 2019
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark, Dirk Klingbiel, Ulrich Mey, et al.
Clinical Genitourinary Cancer
|
September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry
Frank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Urologic Oncology
|
December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group
Christoph Seidel, Karin Oechsle, Anja Lorch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2017
Sensitivity Comparison of <sup>68</sup>Ga-OPS202 and <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P Nicolas, Nils Schreiter, Felix Kaul, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
European Urology Oncology
|
August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
Joe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
BMC Medical Informatics and Decision Making
|
August 27, 2013
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
Kerri M Clough-Gorr, Lea Noti, Peter Brauchli, et al.
Prostate Cancer and Prostatic Diseases
|
April 8, 2024
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials
Mohamed Shelan, Vérane Achard, Felix Appiagyei, et al.
Lancet (London, England)
|
September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Eva Compérat, Mahul B Amin, Richard Cathomas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 27, 2013
Multidisciplinary care in patients with prostate cancer: room for improvement
Räto T Strebel, Tullio Sulser, Hans-Peter Schmid, et al.
BMC Urology
|
September 11, 2019
Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience
Christoph Oehler, Michel Zimmermann, Lukas Adam, et al.
Clinical Genitourinary Cancer
|
January 29, 2019
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark, Dirk Klingbiel, Ulrich Mey, et al.
Clinical Genitourinary Cancer
|
September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry
Frank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Urologic Oncology
|
December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group
Christoph Seidel, Karin Oechsle, Anja Lorch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2017
Sensitivity Comparison of <sup>68</sup>Ga-OPS202 and <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P Nicolas, Nils Schreiter, Felix Kaul, et al.
Page
of 14